Business Description
Physiomics Plc is an Oxford-based company founded in 2001 that helps drug developers make better decisions through advanced computer modeling and data analysis. Using its own Virtual Tumour software, the company specializes in cancer research, predicting how tumors respond to treatment to speed up and improve the drug development process. It also works toward tailoring medical treatments to individual patients. Physiomics serves clients across the UK, US, and Europe.